KRM Ayurveda Limited operates a network of hospitals and clinics in India as well as abroad through telemedicine consulting and sales. The company provides treatment for kidney disorders, liver cirrhosis, diabetes, fatty liver, and arthritis. It also offers panchakarma therapies, abhyanga (oil massage), shirodhara, herbal steam baths, udvartana (herbal powder massage), chakra healing, orthopedic care, skin and hair care, women’s wellness, geriatric care, stress management, weight management, preventive health plans, and personalized nutrition and yoga consultation. In addition, it provides herbal medicines. The company was incorporated in 2019 and is based in Delhi, India.
| Current Price | ₹245.00 |
|---|---|
| Market Cap | ₹556 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Pharmaceutical Contract Manufacturing Services |
| P/E Ratio | 25.9 |
| 52-Week Range | ₹266.00 – ₹281.95 |
| Beta (1Y) | 0.95 |
| Revenue | ₹32 Cr |
|---|---|
| Net Profit | ₹9 Cr |
| EPS (Basic) | ₹4.27 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
1. Healthcare Facilities & Services-100%
KRM Ayurveda Limited is trading at ₹245.00, with a market capitalisation of ₹556 Cr.
KRM Ayurveda Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Contract Manufacturing Services).
KRM Ayurveda Limited has a P/E of 25.9.
In Q1 FY27, KRM Ayurveda Limited reported revenue of ₹32 Cr and net profit of ₹9 Cr, with basic EPS of ₹4.27 (standalone, parsed from the company's exchange filing).